Christophe Mossé appointed as CEO of Arkopharma group
He will oversee Arkopharma’s activities and related activities of Dermapharm Group.
Brings industry expertise from leading groups: Naos, Galderma, Novartis,…
Founded in 1980 in Carros, near Nice, Arkopharma is a pharmaceutical laboratory specialized in phytotherapy, natural medicines, and dietary supplements.
Arkopharma, a European leader in its field, has announced the arrival of Christophe Mossé as CEO (cf. LinkedIn post below)
Christophe Mossé brings a wealth of experience in the pharmaceutical industry, both in France and internationally.
With his expertise, Christophe Mossé will lead Arkopharma’s activities and related operations of Dermapharm Group, and will be the main link between the management teams of the two entities.
Arkopharma is now present in more than 60 countries and is positioned as the European leader in phytotherapy medicines and dietary supplements.
With 1,212 employees and a consolidated turnover of 201 million euros, Arkopharma dedicates 8.5% of its workforce to research and development, with 1,635 registrations and marketing authorizations for medicines.
Health Nice Côte d’Azur
- INNOVA 2026: Université Côte d’Azur hosts its international conference on ageing and well-being in Nice, November 25 and 26
- Life Sciences Afterwork: bringing together the Côte d’Azur’s established and newly arrived innovators, October 1 in Nice
- Eurobiomed H1 2026 review: nearly €250 M mobilised by the HealthTech industry in Southern France
- ExAdEx-Innov secures a U.S. patent on its technology for human ex vivo tissue models
- Nice University Hospital launches Health Data Warehouse to advance medical research and innovation
- 6th Life Sciences Afterwork organised by Team Nice Côte d’Azur
- Follow Health (Nice) joins European software group Orisha
- The Nice University Hospital performs its 100th liver transplantation since 2024
- Obesity: French first at Nice University Hospital
- Team Nice Côte d’Azur at the Van Lanschot Kempen Life Sciences Conference 2026
